Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cresco Labs (CRLBF) EPS (Weighted Average and Diluted) (2020 - 2023)

Historic EPS (Weighted Average and Diluted) for Cresco Labs (CRLBF) over the last 3 years, with Q4 2023 value amounting to $0.01.

  • Cresco Labs' EPS (Weighted Average and Diluted) changed N/A to $0.01 in Q4 2023 from the same period last year, while for Dec 2023 it was $0.01, marking a year-over-year change of. This contributed to the annual value of -$0.22 for FY2024, which is 5925.93% up from last year.
  • Latest data reveals that Cresco Labs reported EPS (Weighted Average and Diluted) of $0.01 as of Q4 2023.
  • In the past 5 years, Cresco Labs' EPS (Weighted Average and Diluted) ranged from a high of $111200.0 in Q3 2020 and a low of -$227432.8 during Q3 2021
  • For the 3-year period, Cresco Labs' EPS (Weighted Average and Diluted) averaged around -$37279.3, with its median value being -$16442.3 (2020).
  • Examining YoY changes over the last 5 years, Cresco Labs' EPS (Weighted Average and Diluted) showed a top increase of 30452.59% in 2021 and a maximum decrease of 30452.59% in 2021.
  • Cresco Labs' EPS (Weighted Average and Diluted) (Quarter) stood at -$32884.6 in 2020, then crashed by 591.61% to -$227432.8 in 2021, then surged by 100.0% to $0.01 in 2023.
  • Its last three reported values are $0.01 in Q4 2023, -$227432.8 for Q3 2021, and -$32884.6 during Q4 2020.